David Efraim Rosen

David Efraim Rosen has an estimated net worth of $4.59 Billion. This is based on reported shares across multiple companies, which include Vincerx Pharma, Inc., Radius Health, Inc., TherapeuticsMD, Inc., HERON THERAPEUTICS, INC. /DE/, Mereo BioPharma Group plc, Talen Energy Corp, and COLLEGIUM PHARMACEUTICAL, INC.

2022 was David Efraim Rosen's most active year for acquiring shares with 11 total transactions. David Efraim Rosen's most active month to acquire stocks was the month of November. 2025 was David Efraim Rosen's most active year for disposing of shares, totalling 24 transactions. David Efraim Rosen's most active month to dispose stocks was the month of May. 2022 saw David Efraim Rosen paying a total of $46,620,798.89 for 2,394,784 shares, this is the most they've acquired in one year. In 2024 David Efraim Rosen cashed out on 5,245,114 shares for a total of $999,999,899.87, their largest year based on trade value.